← back to search

Helmut J.F. Salzer

Semmelweis University · AT
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include Antifungal resistance and susceptibility, Fungal Infections and Studies, Tuberculosis Research and Epidemiology, and Pneumocystis jirovecii pneumonia detection and treatment.
h-index
30
citations
3,844
works
170
NIH funding
primary concept
Medicine
email

Recent publications

The TB27 Transcriptomic Model for Predicting Mycobacterium tuberculosis Culture Conversion
Pathogens and Immunity 2025cited by 4position: middledoi
Update der S3-Leitlinie: Epidemiologie, Diagnostik und Therapie erwachsener Patienten mit nosokomialer Pneumonie
Pneumologie 2025cited by 4position: middledoi
Key summary of German national guideline for adult patients with nosocomial pneumonia- Update 2024 Funding number at the Federal Joint Committee (G-BA): 01VSF22007
Infection 2024cited by 6position: middledoi
Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland
Respiration 2024cited by 4position: middledoi
Tuberculosis incidence in foreign-born people residing in European countries in 2020
Eurosurveillance 2023cited by 17position: middledoi
Aspergillus-specific IgG antibodies for diagnosing chronic pulmonary aspergillosis compared to the reference standard
Clinical Microbiology and Infection 2023cited by 17position: firstdoi
Therapie bei MDR-, prä-XDR-, XDR-Tuberkulose und Rifampicin-Resistenz oder bei Medikamentenunverträglichkeit gegenüber mindestens Rifampicin
Pneumologie 2023cited by 5position: middledoi
Tuberkulose im Erwachsenenalter
Pneumologie 2022cited by 37position: middledoi
Prediction of anti-tuberculosis treatment duration based on a 22-gene transcriptomic model
European Respiratory Journal 2021cited by 57position: middledoi
Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke
Stroke 2020cited by 283position: middledoi
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Antibiotics 2020cited by 282position: middledoi
Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with <b><i>Pneumocystis jirovecii</i></b> Pneumonia
Respiration 2018cited by 195position: firstdoi
Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives
Respiration 2018cited by 119position: middledoi
Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy
Drug Design Development and Therapy 2018cited by 108position: middledoi
Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary Disease
Respiration 2018cited by 66position: firstdoi
Evaluation of Galactomannan Testing, the Aspergillus-Specific Lateral-Flow Device Test and Levels of Cytokines in Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis
Frontiers in Microbiology 2018cited by 38position: firstdoi
Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997–2017
Journal of Travel Medicine 2018cited by 35position: firstdoi
Pulmonary Diseases in Refugees and Migrants in Europe
Respiration 2018cited by 12position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christoph Lange · Médecins Sans Frontières10 papers (2018–2024)Jan Heyckendorf · Charité - Universitätsmedizin Berlin5 papers (2018–2024)Martin Hoenigl · University of Graz5 papers (2018–2020)Cornelia Feiterna‐Sperling · Charité - Universitätsmedizin Berlin3 papers (2022–2024)Elvira Richter · London School of Hygiene & Tropical Medicine3 papers (2022–2024) · 3 papers (2022–2024) · 3 papers (2022–2024)Folke Brinkmann · Medizinische Hochschule Hannover3 papers (2022–2024) · 3 papers (2022–2024) · 3 papers (2022–2024)Florian P. Maurer · University Medical Center Hamburg-Eppendorf3 papers (2022–2024) · 3 papers (2022–2024) · 3 papers (2022–2024) · 3 papers (2022–2024) · 3 papers (2022–2024) · 3 papers (2022–2024) · 2 papers (2018–2018) · 2 papers (2022–2023)Torsten Bauer · Universitat de Barcelona2 papers (2022–2023)Michael Libman · Centre Hospitalier Universitaire Sainte-Justine2 papers (2018–2018)